APRILE, LARA
 Distribuzione geografica
Continente #
NA - Nord America 2.021
EU - Europa 1.542
AS - Asia 796
SA - Sud America 100
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 3
Totale 4.536
Nazione #
US - Stati Uniti d'America 1.987
GB - Regno Unito 379
RU - Federazione Russa 356
CN - Cina 256
SG - Singapore 252
IE - Irlanda 198
IT - Italia 159
VN - Vietnam 131
SE - Svezia 106
UA - Ucraina 99
DE - Germania 93
BR - Brasile 73
FR - Francia 68
HK - Hong Kong 46
FI - Finlandia 30
ZA - Sudafrica 26
KR - Corea 23
IN - India 21
CA - Canada 16
PL - Polonia 13
BD - Bangladesh 11
MX - Messico 10
JP - Giappone 9
IQ - Iraq 8
ES - Italia 7
AR - Argentina 6
CO - Colombia 6
VE - Venezuela 6
BE - Belgio 5
MY - Malesia 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
ID - Indonesia 4
LT - Lituania 4
NG - Nigeria 4
NL - Olanda 4
PT - Portogallo 4
TN - Tunisia 4
UZ - Uzbekistan 4
AL - Albania 3
AU - Australia 3
BG - Bulgaria 3
CL - Cile 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
IR - Iran 3
PK - Pakistan 3
CR - Costa Rica 2
DK - Danimarca 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
SA - Arabia Saudita 2
SM - San Marino 2
AT - Austria 1
AZ - Azerbaigian 1
BH - Bahrain 1
EG - Egitto 1
EU - Europa 1
GT - Guatemala 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SV - El Salvador 1
UY - Uruguay 1
Totale 4.504
Città #
Southend 335
Dallas 241
Dublin 197
Ashburn 162
Fairfield 160
Singapore 140
San Jose 123
Chandler 111
Woodbridge 102
Santa Clara 93
Moscow 91
Jacksonville 80
Wilmington 69
Beijing 68
Ann Arbor 61
Houston 59
Seattle 54
Milan 48
Cambridge 45
Ho Chi Minh City 45
Hong Kong 43
Council Bluffs 42
The Dalles 42
Hanoi 39
New York 35
Nanjing 32
Princeton 32
Los Angeles 30
Hefei 24
Johannesburg 24
Seoul 23
Siena 20
Lauterbourg 18
Boardman 15
Munich 14
Helsinki 13
Orem 13
São Paulo 13
Shanghai 11
Atlanta 10
Figino 10
Nanchang 10
Poplar 10
Warsaw 10
Buffalo 9
Columbus 9
Nuremberg 9
Tokyo 9
Chennai 8
Da Nang 8
Dong Ket 8
London 8
Denver 7
Florence 7
San Mateo 7
Zhengzhou 7
Brooklyn 6
Chicago 6
Hebei 6
Mexico City 6
San Diego 6
San Francisco 6
Stockholm 6
Tianjin 6
Brussels 5
Montreal 5
Phoenix 5
Rome 5
Shenyang 5
Abuja 4
Baghdad 4
Boston 4
Cagliari 4
Caracas 4
Frankfurt am Main 4
Guangzhou 4
Haiphong 4
Norwalk 4
Poggibonsi 4
Taizhou 4
Tashkent 4
Vancouver 4
Ankara 3
Augusta 3
Brno 3
Cascavel 3
Changsha 3
Curitiba 3
Düsseldorf 3
Hangzhou 3
Hyderabad 3
Lisbon 3
Miami 3
New Delhi 3
Newark 3
Quito 3
Redondo Beach 3
Tunis 3
Vienna 3
Arezzo 2
Totale 3.091
Nome #
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients 303
Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status? 300
Atherothrombotic risk assessment during tyrosine kinase inhibitors treatment in chronic myeloid leukemia patients: new insight? 282
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 268
BCR-ABL Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients with Molecular Minimal Residual Disease During Imatinib: Interim Analysis of a Phase 2 Multicenter GIMEMA CML Working Party Trial 267
Flow-cytometry evaluation of residual Leukemia Stem Cells in Chronic Myeloid Leukemia patients: feasibility and clinical application. 262
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may explain increased atherothrombotic risk during TKI treatment in chronic myeloid leukemia patients 260
Complete molecular response in CML after p210 BCR-ABL1-derived peptide vaccination 253
Peptide vaccines for hematological malignancies: a missed promise? 245
Identification of a Novel P190-Derived Breakpoint Peptide Suitable for Peptide Vaccine Therapeutic Approach in Ph+ Acute Lymphoblastic Leukemia Patients. 244
A solitary uterine relapse in T-cell Acute Lymphoblastic Leukaemia: CT features and pathologic correlation 240
Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib 230
Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy. 223
FLT3 inhibitors in the management of acute myeloid leukemia 221
Evaluation of Residual CD34+/Ph+ Stem Cells In Chronic Myeloid Leukemia Patients In Complete Cytogenetic Response during First Line Nilotinib Therapy 192
Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletion 192
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study 183
Peripheral Blood Flow-Cytometry Chronic Myeloid Leukemia Stem Cells Detection and Quantification during Tyrosine Kinase Inhibitors Therapy 144
null 130
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T‐cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study 97
Totale 4.536
Categoria #
all - tutte 13.061
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.061


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022177 0 0 0 27 14 11 11 7 10 27 23 47
2022/2023359 19 30 48 52 31 79 1 33 35 5 17 9
2023/2024275 12 7 27 4 5 75 109 11 0 5 2 18
2024/2025485 6 19 62 19 72 21 5 23 70 14 64 110
2025/20261.618 97 195 158 212 367 64 209 33 43 97 29 114
2026/2027215 41 39 96 39 0 0 0 0 0 0 0 0
Totale 4.536